全文获取类型
收费全文 | 2854篇 |
免费 | 71篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 25篇 |
基础医学 | 443篇 |
口腔科学 | 74篇 |
临床医学 | 170篇 |
内科学 | 156篇 |
皮肤病学 | 6篇 |
神经病学 | 17篇 |
特种医学 | 317篇 |
外科学 | 1287篇 |
综合类 | 192篇 |
预防医学 | 28篇 |
眼科学 | 5篇 |
药学 | 73篇 |
1篇 | |
中国医学 | 40篇 |
肿瘤学 | 23篇 |
出版年
2023年 | 33篇 |
2022年 | 83篇 |
2021年 | 96篇 |
2020年 | 71篇 |
2019年 | 89篇 |
2018年 | 91篇 |
2017年 | 78篇 |
2016年 | 77篇 |
2015年 | 93篇 |
2014年 | 210篇 |
2013年 | 181篇 |
2012年 | 98篇 |
2011年 | 122篇 |
2010年 | 108篇 |
2009年 | 141篇 |
2008年 | 140篇 |
2007年 | 136篇 |
2006年 | 97篇 |
2005年 | 132篇 |
2004年 | 118篇 |
2003年 | 86篇 |
2002年 | 71篇 |
2001年 | 56篇 |
2000年 | 60篇 |
1999年 | 38篇 |
1998年 | 46篇 |
1997年 | 38篇 |
1996年 | 37篇 |
1995年 | 26篇 |
1994年 | 24篇 |
1993年 | 19篇 |
1992年 | 24篇 |
1991年 | 22篇 |
1990年 | 22篇 |
1989年 | 20篇 |
1988年 | 22篇 |
1987年 | 17篇 |
1986年 | 13篇 |
1985年 | 21篇 |
1984年 | 14篇 |
1983年 | 9篇 |
1982年 | 8篇 |
1981年 | 8篇 |
1980年 | 8篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 9篇 |
1972年 | 7篇 |
1971年 | 6篇 |
1970年 | 10篇 |
排序方式: 共有2964条查询结果,搜索用时 15 毫秒
21.
Interleukin-1-stimulated cartilage degradation in bovine articular cartilage explants is effectively inhibited by several different dithiocarbamates with IC50's in the micromolar range.accepted by W. B. van den BergSupported by OsteoArthritis Sciences, Inc. 相似文献
22.
C. Bosman E. Bonucci P. Gugliantini L. Saguí 《Virchows Archiv : an international journal of pathology》1977,373(1):23-35
Summary An ultrastructural study of chondrodystrophia calcificans congenita is reported. Foci of initial calcification of cartilage are characterized by coexistence of three different types of crystals, probably due to abnormal proteoglycan composition of cartilage matrix. The calcification process in chondrodystrophia calcificans congenita is apparently not related to matrix vesicles as it is in normal cartilage. 相似文献
23.
The studies described here examine the involvement of the fibrinolytic cascade and its endogenous inhibitors in the regulation of activity of matrix metalloproteinases and cartilage degradation related to non-inflammatory joint disease, like osteoarthritis. An interleukin-1-induced model of degradation using [35S]-labeled bovine and human articular cartilage explants was utilized. One goal of these studies was to compare the responses of bovine and human articular cartilage. Degradation was not inhibited by
1-PI, PAI-1,
2-macroglobulin,
2-antiplasmin or TIMP-2, when IL-1 alone was added. Addition of human plasminogen to bovine explants, at concentrations found in human synovial fluid, increased degradation by three to fourfold. Under these conditions, the degradation was inhibited effectively by all of the endogenous inhibitors tested, indicating the presence of a cascade where activated chondrocytes are a source of u-PA. Plasminogen activated by u-PA gives plasmin, which is known to further activate pro-stromelysin. Stromelysin is essential for activation of collegenase. Not only TIMP, but also inhibitors at earlier steps of activation like PAI-1,
2-antiplasmin,
1-PI and
2-macroglobulin inhibited degradation, and could provide cartilage protection in vivo. An experiment with human articular cartilage explants showed that very little or no degradation occurred when human articular cartilage explants were stimulated with interleukin-1 alone. Addition of human plasminogen (at physiologically relevant concentrations) resulted in significant degradation, which was inhibited in the same manner as in bovine explants, by inhibitors of the fibrinolytic cascade and TIMP. TIMP is much more efficient in human explants, indicating the limited participation of human plasmin in the degradation of human cartilage. Although speculative, it is possible that in vivo, cartilage degradation could be promoted not only by TIMP/MMP imbalance, but also accelerated by decreased levels of certain serpins in synovial fluid (e.g. PAIs,
2-antiplasmin and
1-PI).accepted by W. B. van den BergWork supported by OsteoArthritis Science Inc., One Kendall Square, Bldg. 200, Cambridge, MA 01139, USA. 相似文献
24.
Markers of cartilage degradation hold a great, but so far underutilized potential in the research and clinical management of joint diseases such as osteoarthritis (OA) and rheumatoid arthritis (RA). With the rapid pace of development of such markers, they are likely to emerge as promising clinical tools for several uses. These roles may include: improving preclinical and clinical development in arthritis research; differentiation of patients with high and low turnover states at disease diagnosis; selection of optimal therapy and therapy dose for the individual patient; monitoring disease progression; and predicting disease outcome.This review focuses on the cartilage matrix components and the metabolites from this very special tissue that have been proposed as biochemical markers. Special attention is focused on the challenges facing the development of such markers to the standards required for widespread practical use. Examples are provided on the current use of cartilage derived biochemical markers and perspectives for the future use of markers and required clinical documentation are presented. 相似文献
25.
26.
27.
28.
29.
30.